Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
![]() |
![]() |
||||||||
GSM5135103 |
C2_R1 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135104 |
C2_R2 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135105 |
C18_R1 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135106 |
C18_R2 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135107 |
C13_R1 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135108 |
C13_R2 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135109 |
C10_R1 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM5135110 |
C10_R2 ATAC
|
SRA | 1 | Jens Lichtenberg | Mar 03, 2023 | ||||
GSM6746046 |
Control CN1
|
SRA | 1 | Jinsoo Ahn | Mar 03, 2023 | ||||
GSM6746047 |
Control CN2
|
SRA | 1 | Jinsoo Ahn | Mar 03, 2023 | ||||
GSM6746048 |
Parthenote PA1
|
SRA | 1 | Jinsoo Ahn | Mar 03, 2023 | ||||
GSM6746049 |
Parthenote PA2
|
SRA | 1 | Jinsoo Ahn | Mar 03, 2023 | ||||
GSM7054596 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t04, Replicate1
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054597 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t04, Replicate2
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054598 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t04, Replicate3
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054599 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t08, Replicate1
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054600 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t08, Replicate2
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054601 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t08, Replicate3
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054602 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t12, Replicate1
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 | ||||
GSM7054603 |
RNA-seq, HEK293T cells, HBV cccDNA transfection, t12, Replicate2
|
SRA | 1 | Andres Mansisidor | Mar 03, 2023 |